The deal will allow HippoFi to sell Pur Biologics products alongside Precision Spine’s implant portfolio, HippoFi said in an Oct. 5 news release. Pur Biologics is a division of HippoFi.
The partnership is expected to speed up the commercialization of the regenerative products through Precision Spine’s brand recognition.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
